by European Public Health Alliance | May 26, 2016 | Statements
A prominent group of nine leading professors and scientists have written a strongly worded letter to the European Medicines Agency raising serious concerns over the ongoing ’Adaptive Pathways’ pilot project. The pilot, due to be evaluated by June, seeks to accelerate...
by European Public Health Alliance | May 3, 2016 | Opinion
The Dutch Presidency makes moves to shake the medicines accessibility and affordability landscape, questioning the suitability of patents, market exclusivities and monopolies, and announcing draft Council Conclusions on medicines. By Yannis Natsis, @ynatsis Policy...
by European Public Health Alliance | Apr 18, 2016 | Statements
AMSTERDAM —We strongly support the Dutch European Union (EU) Presidency’s critique of the current over-protection and misuse of intellectual property and related rights for pharmaceuticals, and its goal to better balance the reward for innovation against the assurance...
by European Public Health Alliance | Apr 18, 2016 | Statements
20 civil society associations urge Member States to support the Dutch EU Presidency’s vision on access to affordable medicines. Call for backing comes as Health Ministers meet in Amsterdam We strongly support the Dutch European Union (EU) Presidency’s critique of the...
by European Public Health Alliance | Apr 15, 2016 | Statements
An open letter by European Public Health Alliance (EPHA), Association Internationale de la Mutualité (AIM) and European Social Insurance Platform (ESIP) to the Members of the Informal Health Council. TO THE MEMBERS OF THE INFORMAL HEALTH COUNCIL A CALL FOR CONCRETE...
